Literature DB >> 21813720

Improved polyacrylamide-based artificial sputum with formalin-fixed tubercle bacilli for training of tuberculosis microscopists.

Hiroyuki Yamada1, Satoshi Mitarai, Manik Rento Wahyunitisari, Ni Made Mertaniasih, Tetsuhiro Sugamoto, Kinuyo Chikamatsu, Akio Aono, Hiroko Matsumoto, Akiko Fujiki.   

Abstract

Sputum smear microscopy is an easy, inexpensive, and rapid method for detecting tubercle bacilli when there are more than 10,000 bacilli/ml in the original sputum. Furthermore, because the microscopic method provides not only quantitative, but also qualitative information, such as the shape of bacilli, it has remained significant. We have previously developed and reported panel test slides made from polyacrylamide-based artificial sputum (PBAS) mixed with both cultured THP-1 cells and nonpathogenic mycobacteria. In this paper, we report an improved preparation method for PBAS for panel test slides that provides a simplified method and enhanced availability with high consistency in each grade and in which only negative PBAS is prepared from polyacrylamide and cultured THP-1 cells and mixed with graded formalin-fixed Mycobacterium tuberculosis solution (FFTBS) containing oral flora and Pseudomonas aeruginosa on the slides. In the smears prepared using this improved method, the numbers (average ± standard deviation [SD]) of acid-fast bacilli (AFB) in 300 fields (2- by 3-cm smear) in eight smears of each grade ranged from 5 to 9 (6.4 ± 1.4), from 59 to 88 (74.6 ± 10.0), from 503 to 912 (705.0 ± 145.7), and from 1,819 to 3,256 (2133.3 ± 478.0) in ±, +, ++, and +++ smears, respectively. In addition, this preparation method provided high similarity to the microscopic appearance of bacilli and background seen in the actual patient sputum, with high feasibility. These results revealed that our new PBAS had high authenticity in the appearance and consistency in each grade, which could make it valuable as a reliable artificial sputum for the training of microscopists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813720      PMCID: PMC3187339          DOI: 10.1128/JCM.00370-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Quality control of smear microscopy for acid-fast bacilli: the case for blinded re-reading.

Authors:  T N Nguyen; C D Wells; N J Binkin; J E Becerra; D L Pham; V C Nguyen
Journal:  Int J Tuberc Lung Dis       Date:  1999-01       Impact factor: 2.373

2.  [Stability for long-term storage and reproducibility of positivity in the panel test slide prepared with the polyacrylamide-based artificial sputum].

Authors:  Hiroyuki Yamada; Hiroko Matsumoto; Satoshi Mitarai; Akiko Fujiki
Journal:  Kekkaku       Date:  2008-02

3.  Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients.

Authors:  Basu Dev Pandey; Ajay Poudel; Tomoko Yoda; Aki Tamaru; Naozumi Oda; Yukari Fukushima; Binod Lekhak; Basista Risal; Bishnu Acharya; Bishwa Sapkota; Chie Nakajima; Tooru Taniguchi; Benjawan Phetsuksiri; Yasuhiko Suzuki
Journal:  J Med Microbiol       Date:  2008-04       Impact factor: 2.472

4.  Implementation of proficiency testing in conjunction with a rechecking system for external quality assurance in tuberculosis laboratories in Mexico.

Authors:  A Martinez-Guarneros; S Balandrano-Campos; M A Solano-Ceh; F Gonzalez-Dominguez; H B Lipman; J C Ridderhof; A Flisser
Journal:  Int J Tuberc Lung Dis       Date:  2003-06       Impact factor: 2.373

5.  Preparation of mycobacteria-containing artificial sputum for TB panel testing and microscopy of sputum smears.

Authors:  H Yamada; S Mitarai; L Aguiman; H Matsumoto; A Fujiki
Journal:  Int J Tuberc Lung Dis       Date:  2006-08       Impact factor: 2.373

Review 6.  Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.

Authors:  Robert S Wallis; Madhukar Pai; Dick Menzies; T Mark Doherty; Gerhard Walzl; Mark D Perkins; Alimuddin Zumla
Journal:  Lancet       Date:  2010-05-18       Impact factor: 79.321

Review 7.  Tuberculosis bacteriology--priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease.

Authors: 
Journal:  Int J Tuberc Lung Dis       Date:  2005-04       Impact factor: 2.373

8.  Clinical evaluation of TRCRapid M.TB for detection of Mycobacterium tuberculosis complex in respiratory and nonrespiratory specimens.

Authors:  Haruka Tanaka; Haruka Hirose; Yuko Kato; Saori Kida; Eiji Miyajima
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

Review 9.  Advances in the diagnosis of tuberculosis.

Authors:  Christoph Lange; Toru Mori
Journal:  Respirology       Date:  2010-02       Impact factor: 6.424

10.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

  10 in total
  4 in total

1.  Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.

Authors:  Jian Du; Wei Shu; Yuhong Liu; Yufeng Wang; Ying Zhan; Kexin Yu; Jingtao Gao; Liang Li; Yu Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-24       Impact factor: 3.267

Review 2.  Significant roadblocks exist in developing sputum sample libraries for clinical validation of novel in vitro diagnostics.

Authors:  Joshua M Dollow; Justin A Green
Journal:  Drug Des Devel Ther       Date:  2014-01-23       Impact factor: 4.162

3.  A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.

Authors:  Markus Beutler; Sara Plesnik; Marina Mihalic; Laura Olbrich; Norbert Heinrich; Samuel Schumacher; Michael Lindner; Ina Koch; Wolfgang Grasse; Christoph Metzger-Boddien; Sabine Hofmann-Thiel; Harald Hoffmann
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

4.  Spatial multiomic profiling reveals the novel polarization of foamy macrophages within necrotic granulomatous lesions developed in lungs of C3HeB/FeJ mice infected with Mycobacterium tuberculosis.

Authors:  Shintaro Seto; Hajime Nakamura; Tz-Chun Guo; Haruka Hikichi; Keiko Wakabayashi; Akiko Miyabayashi; Toshi Nagata; Minako Hijikata; Naoto Keicho
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.